Skip to main content
. 2019 Apr 3;11(4):163. doi: 10.3390/pharmaceutics11040163

Figure 7.

Figure 7

Figure 7

Risk assessment (second level) (a) with respect to size. (b) with respect to Eugenol:Dacarbazine.